These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3293273)

  • 41. Donor-derived soluble MHC antigens plus low-dose cyclosporine induce transplantation unresponsiveness independent of the thymus by down-regulating T cell-mediated alloresponses in a rat transplantation model.
    Behrens D; Lange K; Fried A; Yoo-Ott KA; Richter K; Fändrich F; Krönke M; Zavazava N
    Transplantation; 2001 Dec; 72(12):1974-82. PubMed ID: 11773898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.
    Benichou G; Takizawa PA; Olson CA; McMillan M; Sercarz EE
    J Exp Med; 1992 Jan; 175(1):305-8. PubMed ID: 1730925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8.
    Chen Z; Cobbold S; Metcalfe S; Waldmann H
    Eur J Immunol; 1992 Mar; 22(3):805-10. PubMed ID: 1547823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence that changes in expression of major histocompatibility complex antigens may underlie the immunosuppressive effect of heat-treated cells in vivo and in vitro.
    Baird MA; Enosawa S; Heslop BF
    Transplantation; 1992 Jun; 53(6):1329-33. PubMed ID: 1376504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interstitial class II-positive cell depletion by donor pretreatment with gamma irradiation. Evidence of differential immunogenicity between vascularized cardiac allografts and islets.
    Stegall MD; Tezuka K; Oluwole SF; Engelstad K; Jing MX; Andrew J; Hardy MA
    Transplantation; 1990 Feb; 49(2):246-51. PubMed ID: 2137652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclosporine A-induced acceptance of major histocompatibility complex-incompatible grafts differs immunologically from class I or minor antigen-mismatched grafts accepted in the absence of immunosuppression.
    Lim SM; White DJ; Calne RY
    Transplant Proc; 1987 Oct; 19(5):4252-3. PubMed ID: 3314024
    [No Abstract]   [Full Text] [Related]  

  • 47. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased islet allograft survival after extended culture by a mechanism other than depletion of donor APCs. Lack of correlation between the elimination of donor MHC class II-positive accessory cells and increased transplantability.
    Ketchum RJ; Moore WV; Hegre OD
    Transplantation; 1992 Aug; 54(2):347-51. PubMed ID: 1496545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of transplantation tolerance in adult rats by vascularized spleen transplantation.
    Suzuki H; Li XH; Miyamoto M; Sano T; Hattori Y; Yamashita A
    Transplantation; 1997 Aug; 64(4):650-4. PubMed ID: 9293881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relative contribution of major histocompatibility complex antigens to the immunogenicity of corneal allografts.
    Treseler PA; Sanfilippo F
    Transplantation; 1986 Apr; 41(4):508-14. PubMed ID: 3515652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of kidney allograft rejection across full MHC barriers by recipient-specific antibodies to class II MHC antigens.
    Priestley CA; Spencer SC; Sawyer GJ; Fabre JW
    Transplantation; 1992 May; 53(5):1024-32. PubMed ID: 1585464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synergism between minor and major histocompatibility antigens in the rejection of cultured allografts.
    La Rosa FG; Talmage DW
    Transplantation; 1985 May; 39(5):480-5. PubMed ID: 3992648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunosuppressive activity of serum from liver-grafted rats. Passive enhancement of fully allogeneic heart grafts and induction of systemic tolerance.
    Kamada N; Shinomiya T; Tamaki T; Ishiguro K
    Transplantation; 1986 Dec; 42(6):581-7. PubMed ID: 3538546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple patterns of MHC class II antigen expression on cellular constituents of rat heart grafts. Lack of correlation with graft survival, but strong correlation with vasculitis.
    Forbes RD; Gomersall M; Darden AG; Guttmann RD
    Transplantation; 1991 May; 51(5):942-8. PubMed ID: 2031276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetics of the antibody response to an endothelial transplantation antigen in the rat.
    Blankert JJ; van Es LA; Kunz HW; Cramer DV; Paul LC
    Hum Immunol; 1986 Feb; 15(2):125-36. PubMed ID: 3949552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Major histocompatibility complex control of NK-related allogeneic lymphocyte cytotoxicity in rats. The contributions of strong and medial transplantation antigens.
    Ager A; Fajumi J; Sparshott SM; Ford WL; Butcher GW
    Transplantation; 1988 Nov; 46(5):762-7. PubMed ID: 3194940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac transplantation in the rat. II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response.
    Cramer DV; Chapman FA; Wu GD; Harnaha JB; Qian SQ; Makowka L
    Transplantation; 1990 Oct; 50(4):554-8. PubMed ID: 2219272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion.
    Quigley RL; Wood KJ; Morris PJ
    Immunology; 1988 Mar; 63(3):373-81. PubMed ID: 2965097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.